Melanotan 1
Afamelanotide
Melanotan 1 (Afamelanotide) is a hormonal & sexual research compound. MC1R-selective melanocortin agonist — drives melanin (tanning/photoprotection) more selectively than MT2.
Melanotan 1 quick facts
| Reported research dose | 250mcg-1000mcg |
| Route | Subq |
| Frequency | 1x Daily |
| Half-life | ~1-2 hrs |
| Forms | Injectable, Nasal |
| Evidence level | Approved (Scenesse, EPP); human |
The 'cleaner' tan peptide — MC1R-selective, so fewer of MT2's side effects.
How Melanotan 1 works
MC1R-selective melanocortin agonist — drives melanin (tanning/photoprotection) more selectively than MT2.
Proposed benefits
Tanning and photoprotection via melanogenesis.
✅ Clinically validated
- Approved in Europe and the US as afamelanotide (Scenesse) for erythropoietic protoporphyria, on randomised trial data showing increased pain-free light exposure. That is a real approval for a real melanocortin analogue.
- No trials for cosmetic tanning.
📊 Correlative data
- Used for tanning and photoprotection. Compared with Melanotan 2 the reported profile is markedly cleaner — little to no nausea, flushing or sexual effect — which is exactly what the selectivity predicts.
🧪 Theoretical / extrapolated
- A selective MC1R agonist — the melanocyte receptor — without meaningful MC3R/MC4R activity.
- That single difference from Melanotan 2 explains the entire difference in experience: MT2 is unselective and hits the appetite and libido receptors too. The shared MC1R action means the mole and skin-check caution applies to both, since stimulating melanocytes is the mechanism in each case.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Melanotan 1 — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- These are melanocortin receptor agonists and they are not selective, which is the whole safety story. MC1R gives the tanning. MC4R gives the nausea, the flushing and the erections. You do not get to choose which receptors respond.
- The mole question is the one that matters. These drive melanogenesis systemically — existing naevi commonly darken and new ones can appear. That is not itself cancer, but it makes melanoma surveillance harder precisely in people using a tanning agent.
What has actually been reported
- Nausea in the first hours after dosing is very common and usually settles with repeated exposure. Facial flushing, spontaneous erections and appetite suppression are all frequently reported.
- Case reports exist of melanoma diagnosed in Melanotan users. Causation is not established and the population self-selects for sun exposure — but 'unproven' is not 'reassuring' here.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- Get a full-body skin check before you start, and photograph your moles. This is the whole mitigation. The predicted problem is that melanogenesis makes surveillance harder — a dated set of baseline photographs is what makes 'has this changed?' answerable later.
- Start at a fraction of the intended dose. The nausea and flushing are MC4R effects that attenuate with exposure, so almost everyone who has a miserable first experience simply started too high.
- Dose in the evening. If the nausea lands, you sleep through the worst of it.
- Sun protection does not become optional because you tan faster. Melanin is partial protection, and the tan is not the part that matters here — the mole surveillance is.
- Any new lesion, or an existing one that changes shape, colour or border, is a dermatologist appointment rather than a forum question.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- No routine marker tracks this. The monitoring here is dermatological, not haematological — get a skin check and photograph your moles before you start.
Don't run this if
- Personal or family history of melanoma, or many atypical moles.
- Any pigmented lesion you have not had looked at.
The honest unknown
- Whether driving melanogenesis for years changes melanoma risk in humans. Nobody has run that study and it is not obvious anyone will.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Where to get Melanotan 1
Buy Melanotan 1 at Flawless Compounds →Melanotan 1 — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Melanotan 1 moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Blood pressure is the thing to watch here and it is not a lab — melanocortin agonists can raise it transiently after dosing.
What to do: Take blood pressure before and an hour after a dose the first few times. That tells you more than any panel.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Melanotan 1 — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →The mechanism-predicted concern that matters is not on a blood panel: melanocortin agonists stimulate melanocytes, so existing moles darkening or changing is the signal to take seriously, and a skin check before starting is the version of a baseline that applies here.
- How to work up to it, and when not to
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- How the forms differ in dose
- Coach Cam's personal notes
Get the complete breakdown for Melanotan 1 — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Melanotan 1
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Complete Blood Count (CBC) with Differential | General baseline — but bloodwork is not the monitoring that matters here |
Check results you already have → · All 102 markers A–Z
Melanotan 1 — frequently asked questions
What is Melanotan 1?
Melanotan 1 (Afamelanotide) is a hormonal & sexual research compound. MC1R-selective melanocortin agonist — drives melanin (tanning/photoprotection) more selectively than MT2.
Is the full Melanotan 1 protocol on this page?
The reported research dose is on this page, along with how Melanotan 1 works and the evidence behind it. The protocol — how to work up to it, frequency, cycle length, time off, what not to stack it with and Coach Cam's notes — is inside the Academy.
What is the half-life of Melanotan 1?
Melanotan 1 has an approximate half-life of ~1-2 hrs, which is part of what determines how often it's dosed.
What forms does Melanotan 1 come in?
Melanotan 1 is available as: Injectable, Nasal.
What's the evidence behind Melanotan 1?
Current evidence level: Approved (Scenesse, EPP); human. Melanotan 1 is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Melanotan 1 protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Melanotan 1 is used for
Melanotan 1 appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.